retatrutide fda approval status november 2025 Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide: FDA Approval Timeline &

Head-to-head data from the SURMOUNT trials showed tirzepatide producing slightly greater weight loss at equivalent treatment durations

Many products are research-grade and may lack consistent quality standards

Eli Lilly narrative, and how this news fits the story These moves line up closely with existing community narratives that focus on GLP-1 capacity constraints, Medicare access, and the need to turn today's blockbuster obesity franchise into a broader, more durable portfolio

Spirulina ( Arthrospira platensis ) used as functional feed supplement or alternative protein source: a review of the effects of different dietary inclusion levels on production performance, health status, and meat quality of broiler chickens

Side Effects Comparison Both medications can cause nausea, vomiting, diarrhea, and stomach discomfort, especially when starting